HIGHLIGHTS
- who: Roberto Maglie from the University of Lu00fcbeck, Germany have published the research work: The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets, in the Journal: (JOURNAL)
- what: The aim of this review is to provide a concise overview of the cytokine milieu of BP, with a special focus on molecules currently under-investigation as potential therapeutic targets.
SUMMARY
Bullous Pemphigoid (BP) represents the most common autoimmune bullous disorder and prevalently occurs in the elderly. CXCL12 activates C-Myc, which promotes B-cell differentiation into antibodysecreting cells and facilitate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.